Related Experiment Video
Updated: Sep 14, 2025

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
Published on: July 18, 2025
Brain‑heart axis: Neurostimulation techniques in ischemic heart disease (Review)
Yunnan Liu1, Haimei Yang2, Jian Xiong1
1The Acupuncture and Massage Institute of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, P.R. China.
Insights
Ischemic heart disease (IHD) involves the brain-heart axis. Neural modulation therapies targeting autonomic dysfunction offer promising new avenues for managing IHD and improving cardiovascular health.
Area of Science:
- Cardiology
- Neuroscience
- Autonomic Nervous System Research
Background:
- Ischemic heart disease (IHD) is a leading global cause of mortality, often stemming from atherosclerosis and coronary microvascular dysfunction.
- IHD can lead to severe complications like heart failure, arrhythmias, and sudden cardiac death, necessitating advanced treatments in later stages.
- The brain-heart axis, mediated by the autonomic nervous system, plays a critical role in cardiovascular regulation and IHD progression.
Purpose of the Study:
- To review the pathophysiology of ischemic heart disease (IHD).
- To examine the intricate role of the nervous system in the development and progression of IHD.
- To explore the potential of neural modulation therapies in managing IHD.
Main Methods:
- Systematic review of existing literature on IHD pathophysiology and the nervous system's involvement.
- Analysis of the impact of autonomic nervous system imbalance on cardiovascular conditions.
- Evaluation of emerging neural modulation techniques, including spinal cord and vagus nerve stimulation.
Main Results:
- Autonomic dysfunction, characterized by sympathetic overactivity and reduced parasympathetic tone, exacerbates IHD by promoting inflammation and vasoconstriction.
- Neural modulation therapies demonstrate potential in restoring autonomic balance and enhancing cardiovascular function.
- The neurocardiac interface is a key target for novel therapeutic interventions.
Conclusions:
- The nervous system significantly influences ischemic heart disease (IHD) pathophysiology.
- Neural modulation therapies represent a promising frontier for treating IHD by targeting the brain-heart axis.
- Further research is needed to address current challenges and knowledge gaps in neural modulation for IHD management.
Abstract:
Ischemic heart disease (IHD), mainly due to atherosclerosis and coronary microvascular dysfunction, continues to be a major cause of mortality worldwide. This condition can escalate to severe complications, including heart failure, arrhythmias and sudden cardiac mortality. In advanced stages, treatments such as coronary artery bypass grafting or percutaneous coronary intervention may be necessary. The brain‑heart axis, which facilitates the interaction between the central nervous system and the cardiovascular system via the autonomic nervous system, is crucial in the management of IHD. An imbalance in autonomic function, marked by increased sympathetic activity and diminished parasympathetic influence, can worsen cardiovascular conditions by promoting inflammation, vasoconstriction and myocardial ischemia. Innovative treatments such as spinal cord stimulation and vagus nerve stimulation show potential in re‑establishing autonomic equilibrium and improving cardiovascular function by influencing the neurocardiac interface. The present review discussed the pathophysiology of IHD and methodically examined the role of the nervous system in this disease. It emphasized the possibilities of neural modulation therapy, while identifying ongoing challenges and areas lacking in current knowledge.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

